| ICD-10-CM-2023 > C00-D49 > D37-D48 > D47 |
D37-D48 | Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes | |
Info: | Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made. | |
Excl1.: | neoplasms of unspecified behavior (D49.-) | |
D47 | Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue | |
D47.0 | Mast cell neoplasms of uncertain behavior | |
Excl1.: | congenital cutaneous mastocytosis (Q82.2) histiocytic neoplasms of uncertain behavior (D47.Z9) malignant mast cell neoplasm (C96.2-) | |
D47.01 | Cutaneous mastocytosis | |
Info: | Diffuse cutaneous mastocytosis Maculopapular cutaneous mastocytosis Solitary mastocytoma Telangiectasia macularis eruptiva perstans Urticaria pigmentosa | |
Excl1.: | congenital (diffuse) (maculopapular) cutaneous mastocytosis (Q82.2) congenital urticaria pigmentosa (Q82.2) extracutaneous mastocytoma (D47.09) | |
D47.02 | Systemic mastocytosis | |
Info: | Indolent systemic mastocytosis Isolated bone marrow mastocytosis Smoldering systemic mastocytosis Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD) | |
Use add'l | , if applicable, any associated hematological non-mast cell lineage disease, such as: acute myeloid leukemia (C92.6-, C92.A-) chronic myelomonocytic leukemia (C93.1-) essential thrombocytosis (D47.3) hypereosinophilic syndrome (D72.1) myelodysplastic syndrome (D46.9) myeloproliferative syndrome (D47.1) non-Hodgkin lymphoma (C82-C85) plasma cell myeloma (C90.0-) polycythemia vera (D45) | |
Excl1.: | aggressive systemic mastocytosis (C96.21) mast cell leukemia (C94.3-) | |
D47.09 | Other mast cell neoplasms of uncertain behavior | |
Info: | Extracutaneous mastocytoma Mast cell tumor NOS Mastocytoma NOS Mastocytosis NOS | |
D47.1 | Chronic myeloproliferative disease | |
Info: | Chronic neutrophilic leukemia Myeloproliferative disease, unspecified | |
Excl1.: | atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-) chronic myeloid leukemia BCR/ABL-positive (C92.1-) myelofibrosis NOS (D75.81) myelophthisic anemia (D61.82) myelophthisis (D61.82) secondary myelofibrosis NOS (D75.81) | |
D47.2 | Monoclonal gammopathy | |
Info: | Monoclonal gammopathy of undetermined significance [MGUS] | |
D47.3 | Essential (hemorrhagic) thrombocythemia | |
Info: | Essential thrombocytosis Idiopathic hemorrhagic thrombocythemia Primary thrombocytosis | |
Excl2.: | reactive thrombocytosis (D75.838) secondary thrombocytosis (D75.838) thrombocythemia NOS (D75.839) thrombocytosis NOS (D75.839) | |
D47.4 | Osteomyelofibrosis | |
Info: | Chronic idiopathic myelofibrosis Myelofibrosis (idiopathic) (with myeloid metaplasia) Myelosclerosis (megakaryocytic) with myeloid metaplasia Secondary myelofibrosis in myeloproliferative disease | |
Excl1.: | acute myelofibrosis (C94.4-) | |
D47.Z | Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue | |
D47.Z1 | Post-transplant lymphoproliferative disorder (PTLD) | |
Code first | complications of transplanted organs and tissue (T86.-) | |
D47.Z2 | Castleman disease | |
Use add'l | , if applicable, human herpesvirus 8 infection (B10.89) | |
Excl2.: | Kaposi's sarcoma (C46.-) | |
D47.Z9 | Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue | |
Info: | Histiocytic tumors of uncertain behavior | |
D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified | |
Info: | Lymphoproliferative disease NOS | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |